NMD4C Hiring a Postdoc to Develop Spinal Muscular Atrophy Decision Aid

We are looking to fill a postdoctoral position to develop a tool to support decisions of families and clinicians in selecting a treatment plan for individuals affected by SMA.

This fellowship is based at the University of British Columbia (UBC) in collaboration with Muscular Dystrophy Canada (MDC) and the NMD4C in a well established and dynamic environment fosters professional development and interdisciplinary research collaborations.

With the support of the research team, the postdoctoral fellow will:

  • Acquire training on the Ottawa Decision Aid Framework
  • Conduct a decision need assessment among SMA leading clinicians and families
  • Develop a tool aid
  • Write a grant proposal for implementation and assessment of the SMA tool to CIHR

For further information please read the full job posting.

The NMD4C is looking for a postdoctoral fellow to develop a decision aid for SMA.

Read next...

BSTC logo

Call for Applications: Join the NMD4C Basic Science Trainee Committee (BSTC)

We are thrilled to announce that the Applications are now open to Join our Basic Science Trainee Committee (BSTC) The Neuromuscular Disease Network for Canada (NMD4C) is inviting applications for our Basic Science Trainee Committee (BSTC) from trainees who are interested in contributing to national initiatives that support the neuromuscular research, clinical, and trainee communities. We…

BSTC logo

BSTC Launches Standard Operating Procedures (SOPs)

We’re pleased to announce the launch of the BSTC Standard Operating Procedures (SOPs), now available through the NMD4C Resource Hub. These SOPs provide standardized guidance for laboratories, clinics, and research programs across Canada, supporting consistent, high-quality neuromuscular care and research. Explore the full SOP Library and other open-access resources designed to advance collaboration and strengthen practices nationwide.

Hope On The Horizon: Trials Treatments and Therapies for DMD, DM1 and MG

Hope on the Horizon: Trials, Treatments and Therapies for DMD, DM1 & MG

Nov 26-28, 2025 | Join us at Hope on the Horizon to learn more about the treatment and clinical trial landscape for Duchenne Muscular Dystrophy, Myotonic Dystrophy Type 1 and Myasthenia Gravis from key experts in the field!